Advertisement
The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.

FDA Approves First Test for Zika in Human Blood

0
The ZIKV Detect 2.0 IgM Capture ELISA is made by Seattle-based InBios
Reading clinical notes can help patients to understand why medications are prescribed and improves medication adherence for some patients

Reading Visit Notes May Improve Medication Management

0
Patients say note reading helps them understand why meds are prescribed, makes them feel in control
The global burden of serious health-related suffering is set to increase 47 percent by 2060

Global Burden of Serious Health-Related Suffering to Double by 2060

0
Fastest increases seen in low-income countries, among older people, and for those with dementia
In healthy adults

Remote Ischemic Preconditioning May Have Neuroprotective Effects

0
Dynamic cerebral autoregulation increased six hours after RIPC, lasts for at least 24 hours
For patients with intracerebral hemorrhage

Antiplatelets Do Not Up Recurrence in Intracerebral Hemorrhage

0
In population with cerebral microbleeds, no increased risk seen for those starting antiplatelet therapy
The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy

FDA Approves First Gene Therapy for Spinal Muscular Atrophy

0
Patients treated with Zolgensma have shown improvement in reaching developmental motor milestones
Migraines in pregnant women are associated with an increased risk for pregnancy-associated hypertension disorders as well as an increased risk for a variety of adverse outcomes in the newborn

Migraines in Pregnancy Tied to Worse Outcomes for Mother, Baby

0
Poor outcomes seen in pregnancy for women and at birth, neonatal, and postnatal periods for infants
For individuals without symptomatic cardiovascular disease

Intracranial Hemorrhage Risk Up With Low-Dose Aspirin

0
Caution advised for low-dose aspirin in individuals without symptomatic cardiovascular disease
Vision impairment is associated with increased subjective cognitive decline-related functional limitations for adults aged 45 years and older

Vision Loss May Up Cognitive Decline-Related Functional Limitations

0
More adults who report visual impairment have subjective cognitive decline-related functional limitations
The vast majority of people at risk for Huntington disease choose not to be tested preemptively

Most At-Risk Opt Out of Genetic Testing for Huntington Disease

0
Lack of cure, inability to 'undo knowledge' primary reasons for not going through with testing